Sarcoïdose et anti-TNF : un effet paradoxal de classe? Analyse des cas de la base française de Pharmacovigilance et revue de la littérature
Therapie, 66 2 (2011) 149-154
Published online: 2011-06-06
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Severe sarcoidosis-like reaction in a patient with Crohn’s Disease treated with infliximab. Any relationship?
Esteban Fuentes-Valenzuela, Claudio Navarro Cañadas, Elda Oyarzún Bahamonde, Miryam Moreta Rodriguez and Jesús BarrioClinics and Research in Hepatology and Gastroenterology 45 (5) 101696 (2021)
https://doi.org/10.1016/j.clinre.2021.101696
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos and Diego JaimesBiomedicines 8 (9) 303 (2020)
https://doi.org/10.3390/biomedicines8090303
Tailored Treatments in Psoriatic Patients
Karolina Vorčáková, Tatiana Péčová, Klára Martinásková, Katarína Nováčeková and Juraj PéčTailored Treatments in Psoriatic Patients (2019)
https://doi.org/10.5772/intechopen.85238
Antibody Engineering
Karolína Vorčáková, Péč Juraj, Péčová Tatiana and Martinásková KláraAntibody Engineering (2018)
https://doi.org/10.5772/intechopen.72449
Etanercept for the treatment of non-radiographic axial spondyloarthritis
Valeria Rios Rodriguez and Denis PoddubnyyExpert Review of Clinical Immunology 12 (5) 493 (2016)
https://doi.org/10.1586/1744666X.2016.1144472
Hypercalcémie majeure révélatrice d’une sarcoïdose induite par étanercept
A. Watrin, M. Royer, E. Legrand and F. GagnadouxRevue des Maladies Respiratoires 31 (3) 255 (2014)
https://doi.org/10.1016/j.rmr.2013.04.029
Improvement with Infliximab of a Disseminated Sarcoidosis in a Patient with Crohn’s Disease
Nader Chebib, Fabrice Piégay, Julie Traclet, François Mion and Jean-François MornexCase Reports in Pulmonology 2014 1 (2014)
https://doi.org/10.1155/2014/368780
Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
Guida Santos, Lourdes Emerenciano Sousa and Alexandre Miguel Bruno Lopes JoãoAnais Brasileiros de Dermatologia 88 (6 suppl 1) 26 (2013)
https://doi.org/10.1590/abd1806-4841.20132487
Etanercept/infliximab
Reactions Weekly 1451 (1) 21 (2013)https://doi.org/10.1007/s40278-013-2954-8
Effect of the TNF‐α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG‐PET
Nils Milman, Niels Graudal, Annika Loft, Jann Mortensen, Janni Larsen and Bo BaslundThe Clinical Respiratory Journal 6 (4) 238 (2012)
https://doi.org/10.1111/j.1752-699X.2011.00276.x
Sarcoidosis Induced by Adalimumab in Rheumatoid Arthritis
Seung Ho Lee, Sa-Il Kim, June Seok Song, et al.Tuberculosis and Respiratory Diseases 71 (6) 464 (2011)
https://doi.org/10.4046/trd.2011.71.6.464